ALSO READIVCA hosted its flagship event, the 7th Annual Conclave in Mumbai China's private funds face employee exodus, business scramble as rules bite PE/VC investments worth USD 3.5 bn in Jan 2018: Report IVCA adds Angel Networks to become one-stop shop for alternative investments in India PE investments decline 60% in Feb with no mega deals: Report
Fulcrum is making a partial exit from Curatio Healthcare a leading dermatology products company, the city-based company said in a statement.
The company would be selling a part of its stake to ChrysCapital for an "undisclosed sum" which manages assets with a size of USD three billion.
For Fulcrum this is second partial exit from Curatio. The first exit from the company was in 2015 when it sold signicant stake to Sequoia, it said.
"Fulcrum invests in early growth companies in pharmaceuticals and healthcare sectors with USD four million turnover. The current deal is another testament to our approach that remaining sector focused and picking a majority stake in early-growth companies", Fulcrum Venture, Managing Partner, Krishna Ramanathan said.
In 2005, Fulcrum picked up majority stake in Curatio in 2005 as a seed stage investor which helped the latter increase its topline to Rs 124 crore in 2017 from Rs 60 crore in 2013.
On the partnership with Fulcrum, Curatio Healthcare, Director, G K Ramani said, "Its capabilities and a niche sector focus helped us to scale multifold and create signficant value for our investors".
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)